SIGA TECHNOLOGIES INC. - COMMON STOCK

SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results

01 May 2024 17:00:00 By Nasdaq GlobeNewswire

SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®

01 Apr 2024 16:05:00 By Nasdaq GlobeNewswire

SIGA Names Larry Miller General Counsel

25 Mar 2024 07:30:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023

12 Mar 2024 16:05:00 By Nasdaq GlobeNewswire

SIGA Declares Special Cash Dividend of $0.60 Per Share

12 Mar 2024 07:30:00 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results

05 Mar 2024 07:30:00 By Nasdaq GlobeNewswire

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

22 Jan 2024 07:30:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023

07 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results

26 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating Countries

23 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

06 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023

08 Aug 2023 16:05:02 By Nasdaq GlobeNewswire

SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®

27 Jul 2023 16:45:00 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on Tuesday, August 8th, 2023 Following Release of Second Quarter 2023 Financial Results

27 Jul 2023 07:30:00 By Nasdaq GlobeNewswire

SIGA CEO Phil Gomez, PhD, to Present on Smallpox and Orthopox Preparedness at NATO Chemical, Biological, Radiological & Nuclear Medical Symposium

27 Jun 2023 16:05:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three Months Ended March 31, 2023

04 May 2023 16:05:01 By Nasdaq GlobeNewswire

SIGA Declares Special Cash Dividend of $0.45 Per Share

04 May 2023 07:30:00 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results

27 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022

02 Mar 2023 16:05:01 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on March 2nd, 2023 Following Release of Fourth Quarter and Full Year 2022 Financial Results

23 Feb 2023 07:30:00 By Nasdaq GlobeNewswire